BACKGROUND: Neurocognitive dysfunction (NCD) continues to occur in a significant number of patients after cardiac procedures. The factors influencing its incidence and severity are not completely known. We hypothesized that hyperglycemia, which is known to exacerbate other forms of cerebral injury, may exacerbate NCD after cardiac operations. METHODS: A total of 525 patients having on-pump coronary artery bypass graft (CABG) procedures underwent cognitive testing at baseline and 6 weeks postoperatively. Multivariable linear regression was used to determine the relationship between NCD and intraoperative hyperglycemia (glucose > or = 200 mg/dL). Diabetic and nondiabetic patients were analyzed separately to eliminate a possible confounding effects between diabetes and hyperglycemia. RESULTS: In the nondiabetic patients, even after controlling for age, years of education, and baseline cognitive function, hyperglycemia was associated with a decrease in cognitive function at 6 weeks (p = 0.0351). Hyperglycemia had no effect on cognitive function in diabetic patients, however. CONCLUSIONS: These findings suggest that in nondiabetic patients undergoing CABG operations, intraoperative hyperglycemia is associated with an increased risk of NCD.
BACKGROUND:Neurocognitive dysfunction (NCD) continues to occur in a significant number of patients after cardiac procedures. The factors influencing its incidence and severity are not completely known. We hypothesized that hyperglycemia, which is known to exacerbate other forms of cerebral injury, may exacerbate NCD after cardiac operations. METHODS: A total of 525 patients having on-pump coronary artery bypass graft (CABG) procedures underwent cognitive testing at baseline and 6 weeks postoperatively. Multivariable linear regression was used to determine the relationship between NCD and intraoperative hyperglycemia (glucose > or = 200 mg/dL). Diabetic and nondiabeticpatients were analyzed separately to eliminate a possible confounding effects between diabetes and hyperglycemia. RESULTS: In the nondiabeticpatients, even after controlling for age, years of education, and baseline cognitive function, hyperglycemia was associated with a decrease in cognitive function at 6 weeks (p = 0.0351). Hyperglycemia had no effect on cognitive function in diabeticpatients, however. CONCLUSIONS: These findings suggest that in nondiabeticpatients undergoing CABG operations, intraoperative hyperglycemia is associated with an increased risk of NCD.
Authors: Miles Berger; Jacob W Nadler; Jeffrey Browndyke; Niccolo Terrando; Vikram Ponnusamy; Harvey Jay Cohen; Heather E Whitson; Joseph P Mathew Journal: Anesthesiol Clin Date: 2015-07-16
Authors: Miles Berger; Niccolò Terrando; S Kendall Smith; Jeffrey N Browndyke; Mark F Newman; Joseph P Mathew Journal: Anesthesiology Date: 2018-10 Impact factor: 7.892
Authors: Joseph P Mathew; William D White; David B Schinderle; Mihai V Podgoreanu; Miles Berger; Carmelo A Milano; Daniel T Laskowitz; Mark Stafford-Smith; James A Blumenthal; Mark F Newman Journal: Stroke Date: 2013-10-08 Impact factor: 7.914
Authors: Monique T Fontes; R Cameron Swift; Barbara Phillips-Bute; Mihai V Podgoreanu; Mark Stafford-Smith; Mark F Newman; Joseph P Mathew Journal: Anesth Analg Date: 2013-01-09 Impact factor: 5.108
Authors: David L McDonagh; Miles Berger; Joseph P Mathew; Carmelo Graffagnino; Carmelo A Milano; Mark F Newman Journal: Lancet Neurol Date: 2014-04-02 Impact factor: 44.182